A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.
Indian Immunologicals partners with ICMR for clinical development of India's first Zika vaccine, funded by ICMR.
Broad spectrum' nanovaccine can target multiple coronaviruses, says team at institute once in spotlight over Covid lab leak theory Researchers from the Wuhan Institute of Virology in China have ...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading higher by 20% to 17 cents during Monday’s session after ...
India’s first mpox case, and what it means for the country’s public health landscape, a new senior citizen health cover ...
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax), By Type (Recombinant Vaccine), By End-use (Private ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback